Literature DB >> 8881444

Comparison of tests of stress-released cortisol secretion in pituitary disease.

S M Orme1, S R Peacey, J H Barth, P E Belchetz.   

Abstract

OBJECTIVES: We wished to compare peak and incremental rise in plasma cortisol in response to insulin induced hypoglycaemia (IIH) stress test, i.m. glucagon stimulation test (IMGST) and short Synacthen test (SST) in patients with pituitary disease, using a modern radioimmunoassay for cortisol. We compared the three stimulants using receiver operator characteristic (ROC) plots, assuming a cortisol threshold of 500 nmol/l or 580 nmol/l for the IIH stress test which we used as the standard from which to evaluate the SST and the IMGST. PATIENTS AND
DESIGN: We prospectively studied 16 patients (8F, 8M mean age 43.69 +/- 3.72 years) admitted to the investigation ward for IIH stress test and who were asked to undergo two additional tests (IMGST and SST) on consecutive days. MEASUREMENTS: We measured serum cortisol at baseline, 30, 45, 60, 90 and 120 minutes during the IIH stress test; baseline, 150 and 180 minutes during GST, and baseline and 30 minutes during the SST.
RESULTS: There was a significant rise in cortisol from baseline in all tests (P < 0.001). There was no significant difference among the peak plasma cortisol responses or the incremental rises in plasma cortisol following IMGST, SST and IIH stress test (repeated measures ANOVA F = 0.704, P = 0.503; F = 0.238, P = 0.79). The ROC plots clearly showed that the SST has poor diagnostic utility at both IIH thresholds, compared with the IMGST.
CONCLUSION: The peaks and incremental rises in cortisol following all three tests are comparable. Using the insulin induced hypoglycaemia stress test as a reference and peak cortisol thresholds of 500 and 580 nmol/l as discriminating variables, the short Synacthen displayed poor diagnostic utility when compared to the i.m. glucagon stimulation test. The short Synacthen may be misleading if used as a screening test as advocated by a number of authors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881444     DOI: 10.1046/j.1365-2265.1996.d01-1562.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  An evidence-base for laboratory endocrinology?

Authors:  Julian H Barth
Journal:  Clin Biochem Rev       Date:  2008-08

2.  Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.

Authors:  Amir H Hamrahian; Kevin C J Yuen; Murray B Gordon; Karen J Pulaski-Liebert; James Bena; Beverly M K Biller
Journal:  Pituitary       Date:  2016-06       Impact factor: 4.107

Review 3.  Preoperative assessment for pituitary surgery.

Authors:  Olivia Pereira; John S Bevan
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 4.  Secondary hypoadrenalism.

Authors:  Giuseppe Reimondo; Silvia Bovio; Barbara Allasino; Massimo Terzolo; Alberto Angeli
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  Copeptin under glucagon stimulation.

Authors:  Krzysztof C Lewandowski; Andrzej Lewiński; Elżbieta Skowrońska-Jóźwiak; Magdalena Stasiak; Wojciech Horzelski; Georg Brabant
Journal:  Endocrine       Date:  2015-11-17       Impact factor: 3.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.